These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


69 related items for PubMed ID: 3927661

  • 1. Application of rapid and simultaneous measurement of sex steroid hormones to the monitoring of gonadotropin therapy.
    Hayata K, Hayashi N, Sekiba K.
    Acta Med Okayama; 1985 Jun; 39(3):161-70. PubMed ID: 3927661
    [Abstract] [Full Text] [Related]

  • 2. Plasma hormones in human gonadotropin induced ovulation.
    Wu CH.
    Obstet Gynecol; 1977 Mar; 49(3):308-13. PubMed ID: 840459
    [Abstract] [Full Text] [Related]

  • 3. Rapid and simultaneous measurement of estrone, estradiol, estriol and estetrol in serum by high performance liquid chromatography with electrochemical detection.
    Hayashi N, Hayata K, Sekiba K.
    Acta Med Okayama; 1985 Apr; 39(2):143-53. PubMed ID: 4003113
    [Abstract] [Full Text] [Related]

  • 4. Serial monitoring of serum estradiol and progesterone levels during the HMG-HCG therapy in sex anovulatory women.
    Sakuragi N, Tanaka T, Fujimoto S, Ichinoe K.
    Int J Gynaecol Obstet; 1981 Mar; 19(1):53-6. PubMed ID: 6111497
    [Abstract] [Full Text] [Related]

  • 5. Monitoring of ovulation induction with HMG-HCG therapy by plasma estrogen and progesterone.
    Muechler EK, Kohler D, Huang KE.
    Int J Fertil; 1981 Mar; 26(4):273-8. PubMed ID: 6120908
    [Abstract] [Full Text] [Related]

  • 6. Serum 17beta-estradiol. Index of follicular maturation during gonadotropin therapy.
    Notation AD, Tagatz GE, Steffes MW.
    Obstet Gynecol; 1978 Feb; 51(2):204-9. PubMed ID: 622235
    [Abstract] [Full Text] [Related]

  • 7. Methods for monitoring follicle maturation decrease; the ovarian hyperstimulation syndrome during gonadotropin treatment.
    Fujita Y, Tasaka K, Miyake A, Aono T, Tanizawa O.
    Eur J Obstet Gynecol Reprod Biol; 1989 Sep; 32(3):223-5. PubMed ID: 2507369
    [Abstract] [Full Text] [Related]

  • 8. Luteinizing hormone bioactivity in human menopausal gonadotropin/human chorionic gonadotropin-induced cycles.
    Abuzeid MI, Yeoman R, Aksel S.
    Fertil Steril; 1987 Feb; 47(2):238-43. PubMed ID: 3102284
    [Abstract] [Full Text] [Related]

  • 9. Human menopausal gonadotropin/human chorionic gonadotropin-induced ovarian hyperstimulation with transient hyperprolactinemia: steroidogenesis enhanced during bromocriptine therapy in monkeys.
    Collins RL, Williams RF, Hodgen GD.
    J Clin Endocrinol Metab; 1984 Oct; 59(4):727-33. PubMed ID: 6434577
    [Abstract] [Full Text] [Related]

  • 10. Ovarian hyperstimulation syndrome following ovulation induction with human menopausal gonadotropin.
    Tulandi T, McInnes RA, Arronet GH.
    Int J Fertil; 1984 Oct; 29(2):113-7. PubMed ID: 6148315
    [Abstract] [Full Text] [Related]

  • 11. Early detection of multiple gestations following hMG-hCG therapy by ultrasonography and midluteal phase progesterone determinations.
    Tanaka T, Sakuragi N, Fujimoto S, Ichinoe K, Mizoe J.
    Int J Fertil; 1983 Oct; 28(3):184-7. PubMed ID: 6140241
    [Abstract] [Full Text] [Related]

  • 12. Male to female ratio after gonadotropin-induced ovulation.
    Ben-Rafael Z, Matalon A, Blankstein J, Serr DM, Lunenfeld B, Mashiach S.
    Fertil Steril; 1986 Jan; 45(1):36-40. PubMed ID: 3080345
    [Abstract] [Full Text] [Related]

  • 13. [A simplified quick semi-quantitative determination of urinary estrogen in non-pregnant female: the application for monitoring of follicular maturation at HMG-HCG therapy].
    Kamata S.
    Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jan; 38(1):64-72. PubMed ID: 3081668
    [Abstract] [Full Text] [Related]

  • 14. [Progress in sterility therapy. Gonadotropin treatment, monitoring follicle maturation using real-time ultrasonics].
    Schmidt W, von Holst T.
    Fortschr Med; 1981 Jul 23; 99(27-28):1080-6. PubMed ID: 6790397
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [The change of plasma hormonal patterns following gonadotropin therapies (author's transl)].
    Matsuoka M.
    Nihon Sanka Fujinka Gakkai Zasshi; 1982 Feb 23; 34(2):143-52. PubMed ID: 6801159
    [Abstract] [Full Text] [Related]

  • 17. Ovulation induction with gonadotropins in women with polycystic ovary disease.
    Kupferminc MJ, Lessing JB, Peyser MR.
    J Reprod Med; 1991 Jan 23; 36(1):61-4. PubMed ID: 1901089
    [Abstract] [Full Text] [Related]

  • 18. [Monitoring of follicles by ultrasonography during induction with HMG-HCG treatment--especially on the prevention of side effects].
    Ishimaru T, Okamoto S, Kajimura H, Masuzaki H, Huang HJ, Fuchi T, Yamashita T, Imamura S, Imamichi S, Hata T.
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 May 23; 37(5):721-9. PubMed ID: 3923140
    [Abstract] [Full Text] [Related]

  • 19. Pre-ovulatory plasma levels of 17beta-oestradiol (E2) and conception in patients treated with gonadotrophins.
    Ferin J, Thomas K, De Hertogh R.
    Acta Endocrinol Suppl (Copenh); 1977 May 23; 214():33-42. PubMed ID: 268747
    [Abstract] [Full Text] [Related]

  • 20. The role of growth hormone (GH), GH-receptor and GH-binding protein in reproduction and ovulation induction.
    Blumenfeld Z, Amit T.
    J Pediatr Endocrinol Metab; 1996 May 23; 9(2):145-62. PubMed ID: 8887137
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.